GL1X · GenesisL1 explorer

MolNFT v1 · #161367 · protein

PCNA complex with CDT2 C-terminal pip-box peptide

6QC0 · Proliferating cell nuclear antigen: “PCNA complex with CDT2 C-terminal pip-box peptide”. X-ray diffraction, 5 pockets (best druggability 0.45). MolNFT v1 #161367 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6QC0
Type
protein
Length
797 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proliferating cell nuclear antigen; Denticleless protein homolog
UniProt
P12004, Q9NZJ0
Pockets
5 · best druggability 0.45

Structure

x-ray diffraction · 3 distinct chains · 18% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProliferating cell nuclear antigenprotein25419% helix, 46% strandP12004
C, EProliferating cell nuclear antigenprotein25518% helix, 47% strandP12004
B, D, FDenticleless protein homologprotein110% helix, 0% strandQ9NZJ0

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.450.7818empty
2820.400.7816empty
31020.380.7521empty
4900.370.7626empty
5870.370.7620empty

Interfaces

6 interfaces between chains.

  • A–C · 771 Ų buried · 18 hydrogen bonds · protein-protein
  • A–E · 751 Ų buried · 15 hydrogen bonds · protein-protein
  • A–B · 747 Ų buried · 2 hydrogen bonds · protein-protein
  • E–F · 739 Ų buried · 8 hydrogen bonds · protein-protein
  • C–D · 686 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6QC0 · PCNA complex with Cdt2 C-terminal PIP-box peptide · the same entry in another collection · chain F against F, TM-score 1.00
  • Q9NZJ0 · AlphaFold monomer V2.0 prediction for denticleless protein homolog (Q9NZJ0) · a predicted model of the same protein · chain F against A, TM-score 0.39

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.